Showing results (1-10 of 290) with videos related to
Sort By:
Pageof 29
Blood|March 18, 2004
Antigen-induced regulatory T cellsStephane Vigouroux, Eric Yvon, Ettore Biagi, et al.Blood|February 17, 2005
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisGianpietro Dotti, Barbara Savoldo, Martin Pule, et al.Blood|July 5, 2003
Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cellsEric S Yvon, Stephane Vigouroux, Raphael F Rousseau, et al.Blood|November 13, 2004
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytesEttore Biagi, Gianpietro Dotti, Eric Yvon, et al.Journal of Virology|September 27, 2003
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytesStéphane Vigouroux, Eric Yvon, Hans-Joachim Wagner, et al.Blood|August 24, 2006
T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cellsJuan Vera, Barbara Savoldo, Stephane Vigouroux, et al.Human Gene Therapy|April 30, 2003
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cellsEttore Biagi, Eric Yvon, Gianpietro Dotti, et al.Cytotherapy|July 13, 2011
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemiaFatma Visal Okur, Eric Yvon, Ettore Biagi, et al.Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cellsEric Yvon, Michele Del Vecchio, Barbara Savoldo, et al.Pageof 29